Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Novel therapies for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) are needed in the setting of reduced antibiotic susceptibilities and therapeutic failure. Ceftaroline is a cephalosporin antibiotic with MRSA activity. Although not FDA approved for MRSA BSI, ceftaroli...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Zasowski, Evan J., Trinh, Trang D., Claeys, Kimberly C., Casapao, Anthony M., Sabagha, Noor, Lagnf, Abdalhamid M., Klinker, Kenneth P., Davis, Susan L., Rybak, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278749/
https://ncbi.nlm.nih.gov/pubmed/27895012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02015-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars